Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial

Background: Epithelial ovarian cancer (EOC) remains the leading cause of gynecologic cancer death worldwide due to the high recurrence rate. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is an alternative modality for platinum-sensitive recurrent EOC. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yuwen, Zhang, Yaxing, Shi, Yuying, Yao, Shijie, Dai, Mengyuan, Cai, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
A New Generation of Cancer Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358559/
https://www.ncbi.nlm.nih.gov/pubmed/35929135
http://dx.doi.org/10.1177/15330338221104565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358559/
https://www.ncbi.nlm.nih.gov/pubmed/35929135
http://dx.doi.org/10.1177/15330338221104565

Ejemplares similares